Related Experiment Video

Updated: Apr 21, 2026

Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module
10:39

Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module

Published on: June 18, 2015

12.4K

Anti-metastatics: an overview of drug candidates in current pipelines

Anne Schaap-Nutt, Dane A Thyssen, David W Drell

  • 1MetaVi Labs Inc, 16238 Ranch Road 620 North, Suite F-347, Austin, Texas 78717, USA. fentschladen@metavilabs.com.

Current Pharmaceutical Design
|October 25, 2014
PubMed

Insights

The pharmaceutical industry is developing anti-metastatic drugs to combat cancer metastasis, a leading cause of death. This review details current drug targets and mechanisms aimed at inhibiting tumor cell migration and spread.

Area of Science:

  • Oncology
  • Pharmacology
  • Molecular Biology

Background:

  • The oncology drug market faces slowed innovation, shifting focus to novel therapeutic strategies.
  • Cancer metastasis is the primary cause of mortality for the majority of cancer patients.
  • This necessitates the development of new agents targeting tumor cell spread.

Purpose of the Study:

  • To review emerging anti-metastatic agents in the pharmaceutical pipeline.
  • To provide an overview of their targets and mechanisms of action.
  • To inform the development of novel metastasis inhibitors.

Main Methods:

  • Literature review of preclinical and clinical studies.
  • Analysis of drug targets involved in tumor cell migration.
  • Examination of mechanisms inhibiting metastasis formation.
  • Survey of agents in the pharmaceutical development pipeline.

Main Results:

  • Identified key molecular targets crucial for tumor cell migration and invasion.
  • Detailed various mechanisms by which anti-metastatic agents function.
  • Cataloged drug candidates currently under investigation for anti-metastatic properties.
  • Highlighted the growing pipeline of anti-metastatic therapies.

Conclusions:

  • Anti-metastatic drug development is a critical and expanding area in oncology.
  • Targeting tumor cell migration and metastasis holds significant therapeutic promise.
  • The reviewed agents represent a new frontier in cancer treatment strategies.

More Related Videos

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

9.2K
Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells10:01

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells

Published on: August 2, 2022

7.3K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
6.9K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.4K
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
8.9K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.2K
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
3.1K
Anthelminthic Agents01:15

Anthelminthic Agents

Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
96